Evaluation of Chronic Pain Patients for Narcotic Therapy: Cautions and Controversies

Similar documents
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Substance Abuse Issues in Pain Management

The Chemical Coper Steven D. Passik, PhD

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

2012 Carilion Prescription Drug Abuse Educational Forum 10/6/2014. Disclosure Statement

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

Painkiller addiction and pseudoaddiction in SCD (presentation 2 in a series of 3)

Test Content Outline Effective Date: June 9, Pain Management Nursing Board Certification Examination

Pain, Addiction & Methadone

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Aberrant Drug-taking Behaviors: What Do We Know?

Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Prescription Medication Abuse: Skills for Prevention and Intervention

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Treatment Agreement

Opioid Agreement for Center for Pain Management S.C.

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

Background & Significance

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Treatment of opioid use disorders

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015

Abstral Prescriber and Pharmacist Guide

How To Write An Opiate Prescription Guideline

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

MQAC Rules for the Management of Chronic Non-Cancer Pain

Review of Pharmacological Pain Management

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

Experiences of Assessing Misuse, Abuse and Opioid Use Disorders in Patients with Pain on Opioid Therapy

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

Treatment of Chronic Pain: Our Approach

Managing Chronic Pain in Adults with Substance Use Disorders

San Mateo County Alcohol and Other Drug Services New Medication Policy

North Bay Regional Health Centre

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Painkillers, addiction and primary care. Dr. L. Goncaras MD, MSc (GP with some knowledge about painkillers and addiction)

Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain

Guidelines for Use of Controlled Substances for the Treatment of Pain

Naltrexone and Alcoholism Treatment Test

AMERICAN ACADEMY OF PAIN MANAGEMENT Prescribing Issue

03/20/12. Recognize the right of patients to appropriate assessment and management of pain

OPIOID PAIN MEDICATION Agreement and Informed Consent

TREATMENT-RESISTANT DEPRESSION AND ANXIETY

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

MENTAL IMPAIRMENT RATING

Medication-Assisted Addiction Treatment

Benzodiazepine Detoxification and Reduction of Long term Use

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

Drug Testing to Support Pain Management

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

CONTROLLED SUBSTANCE CONTRACT

Medical Coverage Policy Monitored Anesthesia Care (MAC)

Karol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Utah Clinical Guidelines on Prescribing Opioids


OVERVIEW OF COGNITIVE BEHAVIORAL THERAPY. 1 Overview of Cognitive Behavioral Therapy

Guidelines for Prescription of Opioid Medications for Acute and Chronic Pain

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

How To Know If You Should Be Treated

Update and Review of Medication Assisted Treatments

Arkansas Emergency Department Opioid Prescribing Guidelines

MEDICAL ASSISTANCE BULLETIN

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

Information for Pharmacists

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management

ADVISORY OPINION THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF CHRONIC PAIN

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Chronic Opioid Use: Comparison of Current Guidelines

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

Southlake Psychiatry. Suboxone Contract

MEDICAL ASSISTANCE BULLETIN

Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence

Assessment and Management of Chronic Pain Guideline Summary

The Addiction Behaviors Checklist: Validation of a New Clinician-Based Measure of Inappropriate Opioid Use in Chronic Pain

Treating Pain: New Guidelines for Using Controlled Substances. Jason F. Arnold, JD, MPH Associate Director, Institute of Human Values in Health Care

Opiate Therapy and Treatment of Chronic Non-cancer Pain. A Clinical Perspective

How To Treat Anorexic Addiction With Medication Assisted Treatment

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

Systems Changes to Improve Opioid Prescribing. Rosemary Mehl MD Physician, Primary Care VA Boston Healthcare System

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

*** Please present this form and all insurance ID cards to the receptionist at this time. ***

Treatment Approaches for Drug Addiction

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

How To Use Naltrexone Safely And Effectively

Transcription:

Evaluation of Chronic Pain Patients for Narcotic Therapy: Cautions and Controversies C. Marcus Cooper, Ph.D., D. N. H. Director Of Psychological Services Pain Medicine Associates Johnson City, Tennessee Disclosure Statement of Financial Interest I, Marc Cooper, Ph.D., DO have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation, they are: Affiliation/Financial Interest: : Director of Psychological Services Name of Organization: : Pain Medicine Associates Disclosure Statement of Unapproved/Investigative Use I, Marc Cooper, Ph.D., Do Not anticipate discussing the unapproved/investigative use of a commercial product/device during this activity or presentation. 1

Evaluation of the Chronic Pain Patient History and Subjective Data Pain history Medical history Surgical history Social history Family history Current Medications / Allergies Complete Review of Systems VAS, Pain Drawing, Pain Disability Index Physical and Objective Data Complete Physical Exam Radiology and Laboratory Assess for function: How is pain interfering with the patients life? Pain Disability Index. Family/home responsibilities Recreation Social Activities Sexual Behavior Self-care Sleeping Occupation Assess for Pre-morbid Function What did the person do prior to the pain problem? Note previous level l of function in all areas of life. See Pain Disability Index Questionnaire What does the person do behaviorally to help the pain? Indications for Chronic Opiate Therapy Consider narcotic therapy when the patient suffers from severe daily pain caused by a disorder for which all accepted medical treatments have failed or are otherwise contraindicated and when the pain is significant interfering with the person s function and quality of life. Is there a pain problem verified by objective diagnostic studies? (Fibromyalgia) 2

Contra-indications or Risk Factors for Narcotic Therapy Pre-existing Psychiatric Disorders vs. co-existing factors Personality and/or behavioral health concerns Social/environmental factors No surgical, alternative, non-opioid or nonpharmacological strategies have been attempted Age Pre-existing Psychiatric Disorders vs. Co-Morbid Psychiatric Disorders Major Depression and/or Bipolar Disorder Personality Disorders: Axis II (especially Borderline) Unstable Marital Relationship History of Alcohol Addiction or current problems Drug Addiction or misuse (including marijuana) Panic Disorder/Anxiety Personality Characteristics, Preexisting Functional Issues prior to pain problem, and other variables. Morbid obesity Deconditioning and sedentary life style Sleep issues Nicotine Dependence Resistance to making any personal changes Age Social risk factors for compliance and successful treatment with opioids Social sec rit disabilit iss es Social security disability issues Litigation/workman s compensation issues Living environment (who is living in the home and why) Area code/local neighborhood 3

General Guidelines for Opioid Therapy Have all other strategies for Pain Management been tried? Having evaluated the patient from a physical, psychological, social, and spiritual point of view (thoroughly evaluating risk factors) proceed with caution. Start low and go slow Remember that all opioid treatment is a trial: not an entitlement program Typically convert to long acting medications Please use caution regarding break through medications Evaluation of Opioid Therapy: Monitoring Outcomes: Is it Working? Critical outcomes: The Four A s Analgesia Is pain relief meaningful? Adverse events Are side effects tolerable? Activities Has functioning improved? Aberrant drug-related behavior 4. Passik SD, Whitcomb L, Kirsch K, et al. Pain outcomes as assessed with a pain assessment and monitoring tool in chronic non-malignant pain patients treated with opioids: results of final analyses. Paper presented at: The International Conference on Pain and Chemical Dependency; June 6-8, 2002; New York, NY. Monitoring Outcomes: Analgesic Is the visual analogue scale improving? Is there meaningful pain relief? Is there improvement in functional activities? i i Note: Remember to document findings Monitoring Outcomes of Opioid Therapy: Side Effects Common: Constipation and somnolence Less common Nausea Amenorrhea Sexual dysfunction Urinary retention Myoclonus Headache Itching Sweating Cognitive Impairment 5. Portenoy RK. Opioid prescribing to patients with and without chemical dependency. Presented at: The International Conference on Pain and Chemical Dependency; June 6-8, 2002: New York, NY. 11. Portenoy RK, Coggins C. Management of opioid side effects. Presented at: The International Conference on Pain and Chemical Dependency; June 6-8, 2002; New York, NY. 4

Monitor Outcomes of Opioid Therapy: Aberrant Behaviors? 1. Preference for short acting medications 2. Running out of medications early/unsanctioned dose escalations 3. Obtaining pain medications from other physicians 4. Borrowing or family member s medication (drugs) More severe aberrant behaviors 1. Obtaining prescription drugs from nonmedical sources (on the street) 2. Concomitant abuse of related illicit drugs (marijuana or other?) 3. Recurrent prescription losses 4. Selling prescription drugs 5. Injecting oral formulation 6. Prescription forgery Monitoring Outcomes: Functional Improvement Improvement in Pain Disability Index Family/home responsibilities Recreation Social activities Sexual behavior Self-care abilities Sleeping Occupation On might even consider physiological measures like bmi, cardiovascular function, bp, hr, or weight loss Improvement in test scores on depression and anxiety (BDS and BAI) Controversies in Narcotic Therapy for Pain Management Providing narcotics to a high risk population Pseudo-addiction issues Pseudo-addiction issues When do you make pain medication contingent on behavioral health changes: stop smoking, weight loss, regular exercise program, etc? Resistance and negotiating compliance. Patients not attending other prescribed pain treatments like physical therapy, acupuncture, etc. 5

Controversy #1: Interventional Strategies especially for moderate to high risk patients Medication agreement Adequate medical management of pain Adequate management of co-morbid anxiety and depression: multi-disciplinary approach Periodic random urine drug screens Pill counts for all controlled substances at all patients visits Controversy #2: Pseudoaddiction Pattern of drug-seeking behavior of pain patients receiving inadequate pain management that can be mistaken for addiction Cravings and some types of aberrant behavior Concerns about availability Clock-watching Unsanctioned dose escalation Resolves with re-establishing analgesia Involve self-help and alternative strategies for pain management 14. Weissman DE, Haddox JD. Opioid pseudoaddiction an iatrogenic syndrome. Pain. 1989;36:363-366. Controversies #3: Crazy, lazy or just non-compliant/resistant? When do you make continuing narcotic therapy dependent upon behavioral health changes. Gaining the cooperation of the patient to make changes to reduce their pain. Resistance issues: Pain medication contingent upon patients actively participating in their own care by following though with prescribed medical care: diagnostic studies and adjunctive treatments. Age and Financial Factors When to Refer to a Multidisciplinary Pain Program Depends on your personal level of comfort, support staff and clinical i loperations and policies i Pre-existing significant psychological factors Are there any therapies (injections or nonpharmacological approaches that you do not offer) that warrant further consideration? Practitioner/patient conflicts 6

Conclusions Chronic pain affects the quality of life of many patients which can be improved with opioids. Healthcare providers need to try first try non-narcotic approaches for pain prior to medications. Narcotics are not an entitlement. Health care providers need to gain the cooperation of the patient in their own recovery process. Healthcare providers need to appropriately assess, treat, and reassess chronic pain, patient compliance and functional improvement. Successful pain management for the moderate to high risk patients includes the utilization of a multi-disciplinary approach, e.g. interventional procedures, medical management, psychological evaluations, alternative strategies, physical therapy, and good rational for treatments. 7